Mahamaya Lifesciences IPO

1.69x

subscribed

Mahamaya Lifesciences IPO

listed
₹2.59LMin. investment
  1. Pre-apply
    10 Nov
  2. Bid start
    11 Nov
  3. Bid end
    13 Nov
  4. Allotment
    14 Nov
  5. Release of funds
    17 Nov
  6. Demat transfer
    17 Nov
  7. Listing
    18 Nov

Mahamaya Lifesciences Limited IPO Details

Price range₹108 – ₹114
IPO type
SME
Lot size1200 shares
Issue size₹70Cr
Red Herring Prospectus
Read
Market Cap
₹266.82CrLower than sector avg
RevenueApr 2024 - Mar 2025
₹264.15CrLower than sector avg
Growth rate3Y CAGR
38.82%

Checklist

Quality analysis
Revenue growth
Company valuation
Earnings expansion
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Compare

Companies in this sector
UPL LtdUPL Ltd
PI Industries LtdPI Industries Ltd
Sumitomo Chemical India LtdSumitomo Chemical India Ltd
Revenue
Higher revenue means strong sales and good market demand
This IPO
₹264.15Cr
This sector
₹2,166.44Cr
Compare with companies
PAT
Higher PAT means strong profitability and efficient cost management
This IPO
₹12.94Cr
This sector
₹120.15Cr
Compare with companies
Market cap
Higher market cap means strong confidence but may suggest overvaluation
This IPO
₹266.82Cr
This sector
₹7,758.76Cr
Compare with companies
P/E ratio
Lower ratio usually means stock is undervalued
This IPO
15.00
This sector
32.38
Compare with companies
D/E ratio
Lower ratio usually means fewer liabilities
This IPO
1.08
This sector
0.50
Compare with companies

Objectives

Capital expenditure
45.77%
Working capital
28.00%
General corporate purposes
16.50%
Purchase of equipment
5.83%
Construction of warehouse building
3.94%

About Mahamaya Lifesciences Limited

Incorporated in 2002, Mahamaya Lifesciences is engaged in the manufacturing of pesticide and bulk formulations catering to Indian agrochemical firms as well as multinational corporations (MNCs). The company operates a manufacturing facility located at Dahej, Gujarat. As of June 30, 2025, it offers a diverse product range including 136 insecticide products, 71 fungicide products, 58 herbicide products, 9 bio-stimulants, 3 biopesticides and 1 Biofertilizer. In FY25 domestic sales accounted for 95.30% of revenues at ₹251.73 crore and exports 4.70% at ₹12.42 crore. Capacity utilisation for solids stood at 113.37%, while that for liquids was 63.77% as of June, 2025. Its dealer network consists of 310+ dealers, spread across 8 states in India, and internationally, the company exports to countries such as Egypt, Turkey and UAE.

Mahamaya Lifesciences IPO Subscription Status

Date
QIB
NII
Retail
Total
11-Nov-25
0.26 times (X)
0.0 times (X)
0.07 times (X)
0.11 times (X)
12-Nov-25
0.26X
0.27X
0.2X
0.42X
13-Nov-25
0.86X
2.82X
1.01X
1.69X

Frequently asked questions

How to invest in the Mahamaya Lifesciences IPO ?

Investors can apply for the Mahamaya Lifesciences IPO through their Demat account via the stock exchange or through their broker.

What is the issue size of Mahamaya Lifesciences IPO ?

The issue size of the Mahamaya Lifesciences IPO is 70 Cr.

What is 'pre-apply' for Mahamaya Lifesciences IPO ?

Pre-applying for an IPO allows you to submit your application before the official subscription period begins.

Which exchanges will Mahamaya Lifesciences IPO shares list on?

The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.